Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Multi-national Multi-institutional Phase 2 Trial for Conversion Surgery in Stage IV or Unresectable Gastric Cancer

NCT03366961 is registered in ClinicalTrials.gov with Cho Hyun Park as lead sponsor.

NCT NCT03366961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03366961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Multi-national Multi-institutional Phase 2 Trial for Conversion Surgery in Stage IV or Unresectable Gastric Cancer
Lead sponsor
Cho Hyun Park
Phase
Not applicable
Overall status
Withdrawn
Start date
December 1, 2017
Completion date
December 31, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage iv or unresectable gastric cancer